Phase 3 Ascites Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites
Decompensated Cirrhosis and Ascites
Aleksander Krag240 enrolled12 locationsNCT05056220
Recruiting
Phase 3
Role of Nutritional Intervention for the Treatment of Sarcopenia in Cirrhotic Patients with Refractory Ascites Candidate to Transjugular Intrahepatic Portosystemic Shunt Placement and Identification of Prognostic Factors Related to Clinical Outcome
Liver CirrhosisSarcopenia in Liver CirrhosisRefractory Ascites in Patients with Cirrhosis
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies72 enrolled2 locationsNCT06814626
Recruiting
Phase 3
Intraperitoneal bevacizumab for recurrent malignant ascites in chemotherapy resistant solid tumours: a randomised trial (REZOLV3R).
Chemotherapy resistant solid tumoursRecurrent malignant ascites
The University of Sydney100 enrolled5 locationsACTRN12624000288527
Completed
Phase 3
The impact of continuous terlipressin infusion on complications of end-stage liver disease
CirrhosisAscitesMalnutrition+2 more
Austin Health30 enrolled1 locationACTRN12619000891123